Webinar: Tryp Therapeutics: Leading the next wave of psychedelic drugs beyond mental health

Published on 28 September 2021

In a recent webinar, we were joined by Tryp Therapeutics’ Chairman & CEO Greg McKee, President & Chief Scientific Officer Jim Gilligan, and CFO Luke Hayes pursuing psilocybin’s potential to transform the treatment of chronic pain and other medical conditions. The presentation includes an overview of the company, the indications, and how theyare leading the next wave of psychedelics beyond mental health.

See more at: https://www.edisongroup.com/edison-tv/

Share this with friends and colleagues